It’s time to take on your enlarged prostate (BPH).
Learn about a non-surgical approach through the RAPID-3 Study • Now enrolling
Millions of men struggle with urinary symptoms caused by an enlarged prostate, or BPH (benign prostatic hyperplasia). Nearly half of men in their 50’s and over 70% of men in their 60’s have BPH.1 As the prostate enlarges, it can cause a range of symptoms such as:
- Frequent need to urinate both day and night
- Weak or interrupted urinary stream
- A sense that you cannot completely empty your bladder
- Urgent feeling of needing to urinate
While there are medications and surgical treatments available for BPH, they do not work for everyone and can also cause unwanted side effects, including sexual dysfunction and urinary incontinence.
If you’re living with BPH and are interested in exploring non-surgical treatment options, you may qualify for the RAPID-3 Clinical Study. The study is for the FloStent™ System – an investigational device designed to relieve BPH symptoms through a simple outpatient procedure.
The FloStent™ System for BPH
A non-surgical approach designed to relieve BPH symptoms
The prostate is about the size of a walnut, and is located at the neck of the bladder. For most men, starting around age 40 their prostate begins to grow. As the prostate enlarges it presses against the urethra, the tube that carries urine out of the body. This pressure blocks the natural flow of urine, causing uncomfortable symptoms and irritation.
The FloStent™ is an investigational device designed to relieve BPH symptoms through a simple outpatient procedure. FloStent is a self-expanding implant that, once positioned, gently re-shapes and opens the narrowed urethra to improve urinary flow. The FloStent procedure does not involve any incisions allowing patients to return home the same day.
What is the RAPID-3 Study?
The FloStent System is currently being offered at select sites in North America and Australia through the RAPID-3 Clinical Study. If you qualify and decide to join the study, you will receive all study-related care at no cost to you. You will also be compensated for your time and travel to attend periodic visits at your study doctor’s office to discuss your experiences and evaluate your progress.
See If You Qualify
To see if you might qualify for the RAPID-3 Study, and to get connected with your local study center to learn more, please take the pre-screening questionnaire below:
1. Berry, et al., Journal of Urology 1984